Literature DB >> 10457983

Hormone replacement therapy: women's decision-making process.

J B Jones1.   

Abstract

Making an informed decision about whether to take hormone replacement therapy to offset short- and/or long-range effects of decreased estrogen due to menopause is particularly important because of the health-related risks and benefits associated with hormone replacements. A qualitative study was conducted in which a cohort of menopausal women were interviewed for the purpose of investigating their decision-making process regarding HRT. Findings illuminate the major factors contributing to the decision, the kinds and sources of information used in arriving at a decision, the decision-making process followed, and whether the decision was informed. Clinical and research implications of the findings are examined.

Entities:  

Mesh:

Year:  1999        PMID: 10457983     DOI: 10.1300/J010v28n03_06

Source DB:  PubMed          Journal:  Soc Work Health Care        ISSN: 0098-1389


  4 in total

1.  "I'd rather go and know": women's understanding and experience of DEXA scanning for osteoporosis.

Authors:  Jane C Richardson; Andrew B Hassell; Elaine M Hay; Elaine Thomas
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

2.  Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.

Authors:  Jennifer R Fishman; Michael A Flatt; Richard A Settersten
Journal:  Soc Sci Med       Date:  2015-02-19       Impact factor: 4.634

3.  Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.

Authors:  Robert H Boone; Angela M Cheung; Larisa M Girlan; E Jenny Heathcote
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

4.  Inquiring minds: women's approaches to evaluating complementary and alternative therapies for menopausal symptoms.

Authors:  Esther Suter; Marja J Verhoef; Chris Bockmuehl; Nathalie Forest; Mary Bobey; Gail D Armitage
Journal:  Can Fam Physician       Date:  2007-01       Impact factor: 3.275

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.